HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,374,186 | -2.6% | 161,661 | +0.5% | 0.01% | 0.0% |
Q1 2024 | $13,725,872 | +0.3% | 160,819 | +0.5% | 0.01% | -7.1% |
Q4 2023 | $13,688,241 | -6.2% | 160,078 | -1.8% | 0.01% | -17.6% |
Q3 2023 | $14,595,510 | +5.9% | 162,933 | +0.7% | 0.02% | +13.3% |
Q2 2023 | $13,776,929 | +102712.9% | 161,815 | -0.1% | 0.02% | -11.8% |
Q1 2023 | $13,400 | +4.2% | 161,929 | -1.0% | 0.02% | 0.0% |
Q4 2022 | $12,863 | -99.9% | 163,552 | -0.6% | 0.02% | -5.6% |
Q3 2022 | $12,175,000 | +18.5% | 164,457 | +4.3% | 0.02% | +20.0% |
Q2 2022 | $10,275,000 | +9.3% | 157,636 | +6.0% | 0.02% | +25.0% |
Q1 2022 | $9,405,000 | +21.5% | 148,770 | +1.9% | 0.01% | +33.3% |
Q4 2021 | $7,741,000 | -22.4% | 145,953 | +3.3% | 0.01% | -35.7% |
Q3 2021 | $9,977,000 | +6.8% | 141,333 | +0.8% | 0.01% | +16.7% |
Q2 2021 | $9,346,000 | -38.6% | 140,248 | +2.3% | 0.01% | -42.9% |
Q1 2021 | $15,215,000 | -7.7% | 137,056 | -1.3% | 0.02% | -8.7% |
Q4 2020 | $16,493,000 | +36.0% | 138,887 | -0.1% | 0.02% | +21.1% |
Q3 2020 | $12,130,000 | -5.8% | 139,027 | -3.3% | 0.02% | -9.5% |
Q2 2020 | $12,872,000 | -15.5% | 143,721 | -5.9% | 0.02% | -34.4% |
Q1 2020 | $15,225,000 | -14.2% | 152,774 | -1.1% | 0.03% | +6.7% |
Q4 2019 | $17,754,000 | -9.4% | 154,519 | -0.6% | 0.03% | -16.7% |
Q3 2019 | $19,605,000 | +0.3% | 155,423 | -4.3% | 0.04% | -2.7% |
Q2 2019 | $19,551,000 | +39.8% | 162,467 | +1.7% | 0.04% | +37.0% |
Q1 2019 | $13,981,000 | -12.4% | 159,822 | +0.1% | 0.03% | -22.9% |
Q4 2018 | $15,968,000 | +46.6% | 159,598 | +67.9% | 0.04% | +66.7% |
Q3 2018 | $10,893,000 | +19.8% | 95,068 | -6.3% | 0.02% | +16.7% |
Q2 2018 | $9,096,000 | -1.6% | 101,429 | -19.7% | 0.02% | -5.3% |
Q1 2018 | $9,242,000 | +29.5% | 126,321 | +2.8% | 0.02% | +35.7% |
Q4 2017 | $7,136,000 | +52.0% | 122,859 | +17.4% | 0.01% | +40.0% |
Q3 2017 | $4,696,000 | +16.0% | 104,669 | +2.1% | 0.01% | +11.1% |
Q2 2017 | $4,049,000 | -6.1% | 102,524 | -3.5% | 0.01% | -10.0% |
Q1 2017 | $4,311,000 | +33.5% | 106,271 | +32.3% | 0.01% | +25.0% |
Q4 2016 | $3,229,000 | +6.5% | 80,326 | -4.1% | 0.01% | 0.0% |
Q3 2016 | $3,032,000 | +30.6% | 83,722 | +4.5% | 0.01% | +14.3% |
Q2 2016 | $2,322,000 | -18.6% | 80,107 | -1.8% | 0.01% | -22.2% |
Q1 2016 | $2,853,000 | +17.2% | 81,569 | +8.0% | 0.01% | +12.5% |
Q4 2015 | $2,434,000 | +1.0% | 75,509 | +1.3% | 0.01% | 0.0% |
Q3 2015 | $2,410,000 | -23.1% | 74,574 | -1.6% | 0.01% | -20.0% |
Q2 2015 | $3,134,000 | -19.4% | 75,765 | -12.5% | 0.01% | -9.1% |
Q1 2015 | $3,890,000 | +21.3% | 86,600 | +1.0% | 0.01% | +22.2% |
Q4 2014 | $3,208,000 | +7.9% | 85,735 | +0.7% | 0.01% | 0.0% |
Q3 2014 | $2,974,000 | -4.3% | 85,180 | -3.3% | 0.01% | 0.0% |
Q2 2014 | $3,109,000 | +22.5% | 88,110 | +13.2% | 0.01% | +12.5% |
Q1 2014 | $2,537,000 | -25.4% | 77,834 | -3.6% | 0.01% | -20.0% |
Q4 2013 | $3,401,000 | +10.6% | 80,734 | +4.7% | 0.01% | 0.0% |
Q3 2013 | $3,075,000 | -6.0% | 77,104 | -2.6% | 0.01% | -9.1% |
Q2 2013 | $3,272,000 | – | 79,138 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |